Published in J Infect Dis on December 23, 2013
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun (2015) 1.17
Secondary bacterial infection following first viral or fungal hit: could granulocyte-macrophage colony-stimulating factor help? J Infect Dis (2014) 1.07
Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signaling. Am J Physiol Lung Cell Mol Physiol (2015) 0.89
The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol (2015) 0.89
TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection. EMBO Rep (2015) 0.85
The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med (2014) 0.83
Delivery of GM-CSF to Protect against Influenza Pneumonia. PLoS One (2015) 0.82
Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages. Mediators Inflamm (2014) 0.78
Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy? Mol Cell Pediatr (2016) 0.77
Pulmonary Immunostimulation with MALP-2 in Influenza Virus-Infected Mice Increases Survival after Pneumococcal Superinfection. Infect Immun (2015) 0.77
The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis. Antimicrob Agents Chemother (2014) 0.75
Reply to Roux and Ricard. J Infect Dis (2014) 0.75
Postviral Complications: Bacterial Pneumonia. Clin Chest Med (2016) 0.75
Immunomodulators Targeting MARCO Expression Improve Resistance to Post-influenza Bacterial Pneumonia. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia. PLoS One (2017) 0.75
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med (2005) 2.15
GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med (2011) 1.83
Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med (2005) 1.58
Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis. J Infect Dis (2011) 1.41
Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2005) 1.39
Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol (2006) 1.34
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol (2004) 1.34
Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun (2010) 1.31
Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol (2008) 1.30
IS6110 functions as a mobile, monocyte-activated promoter in Mycobacterium tuberculosis. Mol Microbiol (2004) 1.30
Postnatal tissue-specific disruption of transcription factor FoxN1 triggers acute thymic atrophy. J Biol Chem (2009) 1.29
IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol (2009) 1.27
NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol (2008) 1.26
The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int Immunol (2007) 1.25
NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol (2004) 1.23
Transmission dynamics of tuberculosis in Tarrant county, Texas. Am J Respir Crit Care Med (2002) 1.22
Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. Microbiology (2009) 1.22
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2002) 1.17
The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol Microbiol (2004) 1.12
Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J Immunol (2002) 1.11
Lymphohematopoietic progenitors do not have a synchronized defect with age-related thymic involution. Aging Cell (2007) 1.11
Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc Natl Acad Sci U S A (2008) 1.10
Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV. AIDS Res Hum Retroviruses (2003) 1.08
Priming reverse transcription with oligo(dT) does not yield representative samples of Mycobacterium tuberculosis cDNA. Microbiology (2002) 1.07
ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells. J Immunol (2009) 1.04
Cyclic AMP response element-binding protein positively regulates production of IFN-gamma by T cells in response to a microbial pathogen. J Immunol (2005) 1.03
CREB, ATF, and AP-1 transcription factors regulate IFN-gamma secretion by human T cells in response to mycobacterial antigen. J Immunol (2008) 0.99
NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis. J Immunol (2012) 0.97
IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. J Infect Dis (2009) 0.97
Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med (2004) 0.96
CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosis. J Immunol (2003) 0.94
Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol (2013) 0.94
The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway. J Biol Chem (2011) 0.93
Weighing gold or counting spots: which is more sensitive to diagnose latent tuberculosis infection? Am J Respir Crit Care Med (2006) 0.92
Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses. Tuberculosis (Edinb) (2009) 0.92
Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis (2002) 0.91
Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection. Eur J Immunol (2014) 0.90
Reduced expression of nuclear cyclic adenosine 5'-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen. J Immunol (2002) 0.90
Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen. Hum Immunol (2008) 0.89
The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol Med Microbiol (2003) 0.89
Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses. J Immunol (2012) 0.88
Immunotherapy for tuberculosis: wave of the future or tilting at windmills? Am J Respir Crit Care Med (2003) 0.88
Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis. J Leukoc Biol (2003) 0.87
An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis. J Leukoc Biol (2008) 0.86
Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression. J Infect Dis (2013) 0.86
Deletion of FoxN1 in the thymic medullary epithelium reduces peripheral T cell responses to infection and mimics changes of aging. PLoS One (2012) 0.85
Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis (Edinb) (2009) 0.85
Thyroid transcription factor-1 (TTF-1) gene: identification of ZBP-89, Sp1, and TTF-1 sites in the promoter and regulation by TNF-α in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2011) 0.85
Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis. Vaccine (2009) 0.83
Role of bovine viral diarrhea virus biotype in the establishment of fetal infections. Am J Vet Res (2002) 0.83
c-Maf-dependent growth of Mycobacterium tuberculosis in a CD14(hi) subpopulation of monocyte-derived macrophages. J Immunol (2011) 0.83
NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen. J Immunol (2009) 0.82
Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis. J Infect Dis (2012) 0.81
Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design. Tuberculosis (Edinb) (2011) 0.79
Progress in understanding the human immune responses to Mycobacterium tuberculosis. Tuberculosis (Edinb) (2009) 0.78
Parturient paresis: the old problem and a new strategy. Vet J (2004) 0.75